Cargando…

Comment on Skrebinska et al. Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection? Diagnostics 2022, 12, 133

In their article, Skebrinska and colleagues analysed the potential pitfalls of detecting Helicobacter pylori (H. pylori) by serology, histological (Giemsa) and immunohistochemical (IHC) staining. However, in the Introduction, the authors state: “…IHC is recommended only in individuals with active ga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kocsmár, Éva, Lotz, Gábor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222081/ https://www.ncbi.nlm.nih.gov/pubmed/35741234 http://dx.doi.org/10.3390/diagnostics12061424

Ejemplares similares

Reply to Kocsmár, É.; Lotz, G. Comment on “Skrebinska et al. Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection? Diagnostics 2022, 12, 133”
por: Daugule, Ilva, et al.
Publicado: (2023)

Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection?
por: Skrebinska, Sabine, et al.
Publicado: (2022)

Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides
por: Kocsmár, Éva, et al.
Publicado: (2021)

ECMO in COVID-19: do not blame the tool
por: Vuylsteke, Alain
Publicado: (2021)

Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study
por: Kim, Jewel Ju Ea, et al.
Publicado: (2021)

Analysis of long-term serological and histological changes after eradication of Helicobacter pylori
por: Fukuda, Kensuke, et al.
Publicado: (2022)

Comment on Villalva et al. Antioxidant, Anti-Inflammatory, and Antibacterial Properties of an Achillea millefolium L. Extract and Its Fractions Obtained by Supercritical Anti-Solvent Fractionation against Helicobacter pylori. Antioxidants 2022, 11, 1849
por: Frański, Rafał, et al.
Publicado: (2023)

Don’t blame the messenger: lessons learned for cancer mRNA vaccines during the COVID-19 pandemic
por: Morris, Van K., et al.
Publicado: (2022)

Could Helicobacter pylori cause an abnormal immune response?
por: Sur, Genel, et al.
Publicado: (2017)

The Kardashian index: a measure of discrepant social media profile for scientists
por: Hall, Neil
Publicado: (2014)

If these data could talk
por: Pasquier, Thomas, et al.
Publicado: (2017)

Comment on van den Hurk et al. The Emergence of Japanese Encephalitis Virus in Australia in 2022: Existing Knowledge of Mosquito Vectors. Viruses 2022, 14, 1208
por: Brinkhoff, Michelle Nicole
Publicado: (2023)

Development of serological assays to identify Helicobacter suis and H. pylori infections
por: Matsui, Hidenori, et al.
Publicado: (2023)

Comment on Liu et al. “Discrepancies of Measured SAR between Traditional and Fast Measuring Systems.” Int. J. Environ. Res. Public Health, 2020, 17, 2111
por: Douglas, Mark, et al.
Publicado: (2020)

Helicobacter pylori Gastritis in Children—The Link between Endoscopy and Histology
por: Domșa, Ana-Maria Teodora, et al.
Publicado: (2020)

Diagnostic values of Helicobacter pylori diagnostic tests: stool antigen test, urea breath test, rapid urease test, serology and histology*
por: Kazemi, Shadi, et al.
Publicado: (2011)

Comment on Eschweiler et al. Anatomy, Biomechanics, and Loads of the Wrist Joint. Life 2022, 12, 188
por: Nikolaidis, Pantelis T., et al.
Publicado: (2022)

Comment on Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822
por: De Giorgi, Vincenzo, et al.
Publicado: (2022)

The complexities of SARS-CoV-2 serology
por: Houlihan, Catherine F, et al.
Publicado: (2020)

The important role of serology for COVID-19 control
por: Winter, Amy K, et al.
Publicado: (2020)

Comment on Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781
por: van der Pluijm, Rob W., et al.
Publicado: (2022)

Chlamydia Pneumoniae and Helicobacter Pylori Serology – Importance in Patients with Coronary Heart Disease
por: Grdanoska, Tatjana, et al.
Publicado: (2012)

Value of Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection
por: Sivandzadeh, Gholam Reza, et al.
Publicado: (2023)

Comment on Muzzioli et al. Are Front-of-Pack Labels a Health Policy Tool? Nutrients 2022, 14, 771
por: Aguenaou, Hassan, et al.
Publicado: (2022)

Management of dyspepsia and Helicobacter pylori infection: the 2022 Indonesian Consensus Report
por: Syam, Ari Fahrial, et al.
Publicado: (2023)

Helicobacter Pylori Infection Induces Intestinal Dysbiosis That Could Be Related to the Onset of Atherosclerosis
por: Francisco, Avilés-Jiménez
Publicado: (2022)

Helicobacter pylori Is Associated with miR-133a Expression through Promoter Methylation in Gastric Carcinogenesis
por: Lim, Joo Hyun, et al.
Publicado: (2018)

Could Pirfenidone Also be Effective in Treating Intestinal Fibrosis?
por: Latella, Giovanni, et al.
Publicado: (2020)

Could BCG be used to protect against COVID-19?
por: Redelman-Sidi, Gil
Publicado: (2020)

Better patient identification could help fight the coronavirus
por: Moscovitch, Ben, et al.
Publicado: (2020)

An association of Helicobacter pylori infection with endoscopic and histological findings in the Nepalese population
por: Mandal, Amrendra Kumar, et al.
Publicado: (2019)

Correlation of Serology with Morphological Changes in Gastric Biopsy in Helicobacter Pylori Infection and Evaluation of Immunohistochemistry for H. Pylori Identification
por: Shukla, Shailaja, et al.
Publicado: (2012)

Comment on Patel, B.; Makaryus, A.N. Artificial Intelligence Advances in the World of Cardiovascular Imaging. Healthcare 2022, 10, 154
por: Giansanti, Daniele
Publicado: (2022)

Comment on Guerrero-Romero et al. Magnesium-to-Calcium Ratio and Mortality from COVID-19. Nutrients 2022, 14, 1686
por: Scarpati, Giuliana, et al.
Publicado: (2022)

Comment on Herring et al. The Use of “Retardation” in FRAXA, FMRP, FMR1 and Other Designations. Cells 2022, 11, 1044
por: Bruford, Elspeth
Publicado: (2022)

Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947
por: Lissing, Mattias, et al.
Publicado: (2023)

Comment on Budryn et al. Hydroxybenzoic Acids as Acetylcholinesterase Inhibitors: Calorimetric and Docking Simulation Studies. Nutrients 2022, 14, 2476
por: Zarguan, Ilham, et al.
Publicado: (2022)

Comment on Wijnia, J.W. A Clinician’s View of Wernicke-Korsakoff Syndrome. J. Clin. Med. 2022, 11, 6755
por: Manigrasso, Michele, et al.
Publicado: (2023)

Cross-testing of major molecular markers indicates distinct pathways of tumorigenesis in gastric adenocarcinomas and synchronous gastrointestinal stromal tumors
por: Kocsmár, Éva, et al.
Publicado: (2020)

Tracking SARS-CoV-2 infection in India with serology
por: John, Jacob, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9deqe1lgug703q05tjcrpd3hov